XML 32 R20.htm IDEA: XBRL DOCUMENT v3.25.3
Share-Based Compensation
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company’s share-based compensation plans include the Ziff Davis, Inc. 2024 Equity Incentive Plan (the “2024 Plan”), the 2015 Stock Option Plan (the “2015 Plan”), and 2001 Employee Stock Purchase Plan (the “Purchase Plan”). Collectively, the 2015 Plan and 2024 Plan are referred to herein as the “Plans.” As of September 30, 2025, 435,135 shares underlying options and 2,153,431 restricted stock units were outstanding under the Plans. As of September 30, 2025, there were 1,926,382 additional shares underlying options, shares of restricted stock and other share-based awards available for grant under the 2024 Plan.
Share-Based Compensation Expense
The following table presents the effects of share-based compensation expense in the Condensed Consolidated Statements of Operations during the periods presented (in thousands):
Three months ended September 30,Nine months ended September 30,
2025202420252024
Direct costs
$72 $68 $203 $191 
Sales and marketing1,320 1,014 3,655 2,865 
Research, development, and engineering935 769 2,662 2,930 
General, administrative, and other related costs (1)
9,870 8,310 27,156 24,647 
Total share-based compensation expense$12,197 $10,161 $33,676 $30,633 
(1)Includes expense of $0.1 million related to liability classified awards issued to non-employees of the Company for the three and nine months ended September 30, 2025, respectively.

Restricted Stock and Restricted Stock Units
The Company has awarded restricted stock and restricted stock units to its Board and senior staff pursuant to the Plans. Compensation expense resulting from restricted stock and restricted unit grants is measured at fair value on the date of grant and is recognized as share-based compensation expense over the applicable vesting period. Vesting periods are approximately one year for awards to members of the Company’s Board, generally three or four years for senior staff (excluding market-based awards discussed below), and three to eight years for the Chief Executive Officer. The Company granted 752,246 and 394,994 restricted stock units (excluding market-based awards discussed below) (“RSUs”) during the nine months ended September 30, 2025 and 2024, respectively.
The Company has awarded certain key employees equity classified market-based restricted stock (“PSAs”) and equity classified market-based restricted stock units (“PSUs”) pursuant to the Plans. PSAs and PSUs granted prior to 2024 have vesting conditions that are based on specific stock price targets of the Company’s common stock. PSUs granted in 2024 and 2025 vest in shares of the Company’s stock ranging from 0% to 200% of the award based on the Company’s attainment of a relative Total Shareholder Return (“TSR”) target compared to the TSR of all listed companies in a market index over the respective performance periods. Performance periods for the PSUs granted in 2025 are two and three years. In each of 2024 and 2025, market conditions were factored into the grant date fair value using a Monte Carlo valuation model, which utilized multiple input variables to determine the probability of the Company and all listed companies in the market index achieving the relative TSR targets.
Share-based compensation expense related to an award with a market condition is recognized over the requisite service period using the graded-vesting method regardless of whether the market condition is satisfied, provided that the requisite service period has been completed.
The per share weighted average grant-date fair value of PSUs granted during the nine months ended September 30, 2025 and 2024 was $38.80 and $87.17, respectively.
The assumptions used in determining the weighted-average fair values of PSUs granted during the periods presented are as follows:
Nine months ended September 30,
20252024
Underlying stock price at valuation date$38.19 $66.88 
Expected volatility34.5 %32.9 %
Risk-free interest rate3.9 %4.3 %

Restricted stock award (“RSA”) and PSA activity for the nine months ended September 30, 2025 is set forth below:
RSAs
PSAs
Number of
Shares
Weighted Average
Grant Date
Fair Value
Number of
Shares
Weighted Average
Grant Date
Fair Value
Nonvested at January 1, 202554,829 $68.97 163,181 $36.27 
Granted— $— — $— 
Vested(27,632)$68.97 — $— 
Forfeited
— $— — $— 
Nonvested at September 30, 2025
27,197 $68.97 163,181 $36.27 
  
RSU and PSU activity for the nine months ended September 30, 2025 is set forth below:
RSUs
PSUs
Number of
Shares

Weighted Average Grant Date Fair Value
Number of Shares (1)
Weighted Average Grant Date Fair Value
Outstanding at January 1, 2025652,227 $74.59 520,986 $82.73 
Granted752,246 $37.23 598,676 $38.80 
Vested(249,811)$73.28 (23,477)$78.73 
Forfeited
(42,415)$55.83 (55,001)$58.90 
Outstanding at September 30, 2025
1,112,247 $50.33 1,041,184 $58.19 
(1)Represents the number of shares at 100% achievement.
As of September 30, 2025, share-based compensation cost of $0.5 million is expected to be recognized over a weighted-average period of 0.3 years for RSAs, share-based compensation cost of $39.7 million is expected to be recognized over a weighted-average period of 2.0 years for RSUs, and share-based compensation cost of $25.7 million is expected to be recognized over a weighted-average period of 2.0 years for PSUs. Share based compensation cost for PSAs is fully recognized,